Published: January 03, 2013
EMD Serono and Pfizer Announce FDA Approval of Rebif® Rebidose® (interferon beta-1a)
ROCKLAND, Mass. and NEW YORK, Jan. 3, 2013 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, and Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Rebif(®) Rebidose(®) (interferon beta-1a), a single-use auto-injector for the self-administration of Rebif, a disease-modifying drug used to treat relapsing forms of multiple sclerosis (MS).
To read the complete release at NewsBlaze,
EMD Serono and Pfizer Announce FDA Approval of Rebif® Rebidose® (interferon beta-1a),
Related PRNewswire Releases News
EDMONTON, May 24, 2013 /PRNewswire/ - The Cash Store Financial Services Inc. today announced that it has filed amended and restated consolidated financial statements and MD&A for the years ended September 30, 2012, September 30, 2011 and the ...
President of Naurelle, Kayvan Nahai, brings old world panache and modern sophistication to the freshly blended homes of newlyweds.
TORONTO, May 24, 2013 /CNW/ - Dickson Resources Limited announces that it has acquired an additional 29,200,000 units of AXMIN Inc. at a price of C$0.15 per Unit in connection with the closing of the second tranche of a private placement previously ...
Seven Arts Entertainment Inc. became aware that the public relations agency of an entity known to the Company only as 'IFSG' has issued defamatory and fraudulent statements regarding the activities of the Company at the recent Cannes Film Festival. ...
Influential proxy advisory firms Institutional Shareholder Services and Glass Lewis this week announced their support for a shareholder proposal at Wal-Mart Stores, Inc. asking the company to publicly disclose whether it has clawed back pay from ...
BRAMPTON, ON, May 24, 2013 /CNW/ - Loblaw Companies Limited is advising the public with sensitivity or allergy to sulphites not to consume 1.36L size of President's Choice® White Grape Juice. The product is sold nationally in Loblaw banner ...